BioSpace News Archive

BioForest

Evotec Receives US$ 6.6 m Grant for Drug Discovery in Tuberculosis

Evotec SE announced that the Company has received a US$ 6.6 m grant from The Bill & Melinda Gates Foundation for drug discovery in tuberculosis.

March 24, 2023
·
6 min read
Business

Ryvu Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Ryvu Therapeutics reported financial results for the fourth quarter and the full year ended December 31, 2022, and provided a corporate update.

March 24, 2023
·
9 min read
Genetown

Allarity Therapeutics Announces Reverse Stock Split of Common Stock

Allarity Therapeutics, Inc. announced that it intends to effect a reverse stock split of its common stock, at a ratio of 1 post split share for every 35 pre-split shares.

March 24, 2023
·
8 min read
Genetown

HiberCell to Present Pre-clinical Data on its Novel GCN2 Activator and PERK Inhibitor Programs at the American Association for Cancer Research (AACR) Annual Meeting 2023

HiberCell today announced three pre-clinical poster presentations which will be highlighted at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19 in Orlando, Florida.

March 24, 2023
·
4 min read
Business

Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results

Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs, announced a corporate update and reported its annual results for the year ended December 31, 2022.

March 24, 2023
·
24 min read
Business

Humacyte Announces Fourth Quarter and Year End 2022 Financial Results and Business Update

Humacyte, Inc. today announced financial results for the fourth quarter and year ended December 31, 2022, and highlighted recent corporate accomplishments.

March 24, 2023
·
15 min read